{"url_path":"/sec/gnpx/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities and Use of Proceeds**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1595248/0001437749-26-016755-index.html","accession_number":"0001437749-26-016755","cik":"0001595248","ticker":"GNPX","issuer_name":"Genprex, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1595248/0001437749-26-016755-index.html","primary_entity_key":"0001595248","primary_entity_name":"Genprex, Inc."},"word_count":100,"has_tables":true,"body_markdown":"**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds**\n\n \n\nDuring the three months ended March 31, 2026, we issued and sold the following unregistered securities:\n\n \n\n \n\n \n\nOn January 2, 2026, we issued 5,000 shares of our common stock to the Chairman of our Scientific Advisory Board in consideration for services during the three months ended March 31, 2026.\n\n \n\nThe foregoing issuance of securities was not registered under the Securities Act or the securities laws of any state, and the securities were offered and issued in reliance on the exemption from registration under the Securities Act afforded by Section 4(a)(2)."}